Paris La Défense, FRANCE – January 20, 2026: SGD Pharma, world leader in the primary glass pharmaceutical packaging market and industry leader in sustainability, will present its latest advances in high-performance solutions at Pharmapack Europe, to be held in Paris on January 21 and 22, 2026. On booths 4C11 and 4C17, SGD Pharma will showcase new pharmaceutical packaging products, including moulded and tubular glass bottles, while illustrating the company’s ongoing commitment to responsible manufacturing. This will be the first time that SGD Pharma will present its entire glass packaging portfolio, including tubular products from the acquisition of Alphial.
New innovations for safer and smarter pharmaceutical packaging
SGD Pharma will highlight its rapidly expanding portfolio of innovative glass solutions designed to improve drug integrity, patient safety and operational efficiency. Key solutions presented include:
SEALIAN, a high-performance internal surface treatment offering enhanced chemical durability and superior protection for sensitive medicines.
IDENCY, premium bottles combining high chemical and mechanical resistance, with the same outer diameter as standard tubular glass bottles to facilitate their integration into existing filling lines.
Sterinity EZ-fill®, a high-quality ready-to-use (RTU) platform that enables faster time-to-market and increased flexibility and reliability for pharmaceutical and biotech players.
Alphial tubular products made in Italy: bulbs, vials and RTU solutions.
Alongside these product innovations, SGD Pharma will present:
The Velocity®bottles, developed with Corning, to improve fill & finish efficiency and reduce operational risk through reduced friction coating technology.
Lab Services, une expertise en science du packaging dans le verre, including analytical testing services.
PROSEAL+, an advanced external treatment providing protection against moisture and oxygen.
Expansion in tubular glass, increased capacity and know-how with Alphial
Illustrating its strategic orientation towards global growth and operational excellence, SGD Pharma continues to expand in tubular glass, complementing its already established global leadership in molded glass. Following the acquisition of Alphial in Q4 2025, the company now combines expertise in molded and tubular glass to offer an unmatched portfolio of solutions that meet customer needs for bulbs, vials, and RTU formats. The integration of Alphial’s Italian sites strengthens SGD Pharma’s European footprint, allowing for improved delivery times, industrial capacities and customer responsiveness, particularly for high value-added biopharmaceutical applications.
Decarbonization: leadership driven by meaning
SGD Pharma was once again awarded EcoVadis' Platinum status, with a score of 90, positioning the company as the world leader in pharmaceutical glass manufacturers for sustainable performance. This recognition recognizes SGD Pharma’s continued commitment to environmental, social and ethical excellence across its global facilities, confirmed by robust governance, decarbonization initiatives and responsible procurement practices.
Building on a roadmap validated by the Science Based Targets initiative (SBTi), SGD Pharma is on track to achieve a 42% reduction in carbon emissions by 2030 and 65% by 2040, relative to 2022 levels. The company’s overall sustainability strategy extends from energy efficiency investments to responsible sourcing and employee inclusion.
Olivier Rousseau, CEO of SGD Pharma, comments:
At Pharmapack 2026, we are proud to demonstrate how innovation and sustainability go hand in hand to shape the future of pharmaceutical glass. As a recognised leader in sustainable glass, we have once again been awarded the EcoVadis Platinum medal for our continuous progress. We are committed to decarbonizing the pharmaceutical glass industry faster than anyone else and are working actively, investing heavily, to do even better and go further than ever before to help our customers deliver on their own decarbonization commitments.”
Visit booths 4C11 and 4C17 at Pharmapack to discover SGD Pharma’s portfolio of solutions and meet the teams shaping the next generation of glass packaging innovations.
EZ-fill® is a registered trademark of Stevanato Group and/or its subsidiaries in one or more jurisdictions.